Celluris
PrivateLast Round
Seed
May 30, 2025
Total Funding Raised
$10.04M
Company Overview
Celluris operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Seed round in May 2025.
Celluris is a biotechnology company that develops personalized CAR-T cell immunotherapy for the treatment of hematological and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celluris Comparables
Compare Celluris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellectis | 68% | |
| Recepta Biopharma | 66% | |
| Allogene Therapeutics | 61% |
For institutional investors. Book with your work email.
Celluris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2025 | ||||
| Grant | Nov 4, 2021 | ||||
| Accelerator | Nov 4, 2021 |
For institutional investors. Book with your work email.
Celluris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BiotechTown | Seed, Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2025
$10M raised with participation from BiotechTown.
- Nov 4, 2021
$36K grant from FAPESP
For institutional investors. Book with your work email.
Celluris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celluris's valuation, stock price, and market status.
Is Celluris a public or private company?
Celluris is a private company.
What is the current stock price of Celluris?
Celluris is a private company, so its shares have no public market price. Caplight tracks Celluris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celluris worth (valuation)?
Valuation information for Celluris is not publicly available.
Can I buy Celluris stock?
Celluris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celluris's last funding round?
Celluris's most recent funding round was Seed on May 30, 2025.
Who are the main investors in Celluris?
Key investors in Celluris include BiotechTown, FAPESP.
Will Celluris IPO soon?
No public IPO plans have been announced for Celluris.
How can I track Celluris secondary market activity?
Caplight tracks bids, offers, and trades in Celluris's shares on secondary markets.